LinkedIn

DGAP-News: Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225

Retrieved on: 
Wednesday, July 6, 2022 - 9:04am

Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177 and Ac-225.

Key Points: 
  • Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177 and Ac-225.
  • The agreement covers the development of a validated manufacturing process as well as the GMP-compliant production of clinical investigational products.
  • Ratio Therapeutics will use the newly built GMP suites at the Eckert & Ziegler production site near Boston, MA, USA, from July 2022 for this purpose.
  • As a radiopharmaceutical contract manufacturer, Eckert & Ziegler is able to produce small batches for Phase I, II and III clinical studies and large commercially applicable batch sizes.

DGAP-News: Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance

Retrieved on: 
Wednesday, July 6, 2022 - 7:04am

We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.

Key Points: 
  • We are excited to launch Aurobac together with our partners at Boehringer Ingelheim and bioMrieux, to combine our complementary strengths.
  • We supply the most comprehensive integrated diagnostic solutions to support an appropriate use of antibiotics (antimicrobial stewardship), said Alexandre Mrieux, bioMrieux Chairman and CEO.
  • Our role within the joint venture is to develop and commercialize diagnostic tests, including Companion Diagnostics, which deliver rapid, reliable and actionable results.
  • bioMrieux has over 55 years of diagnostics expertise with more than 75% of its research and development budget focused on antimicrobial resistance.

Fluence Announces India Technology Centre, Underscoring Commitment to the Region and Execution of Global Product Strategy

Retrieved on: 
Wednesday, July 6, 2022 - 6:30am

The Fluence India Technology Centre supports the execution of the companys global product strategy by growing engineering capabilities and scaling global talent and strengthens Fluences local presence in the country.

Key Points: 
  • The Fluence India Technology Centre supports the execution of the companys global product strategy by growing engineering capabilities and scaling global talent and strengthens Fluences local presence in the country.
  • The Fluence India Technology Centre marks a significant milestone for Fluence, becoming the companys first technology centre based entirely in Asia.
  • Together, the companys technology centre teams support Fluences regionally focused operational model and create a strong foundation for new product introductions and regionalized product support.
  • As the companys largest global technology team, employees at the India Technology Centre are working in the areas of enclosure, battery, and inverter engineering, software quality assurance, product management, and more.

Arab Fund for Economic and Social Development Names Northern Trust Its Asset Servicing Provider

Retrieved on: 
Wednesday, July 6, 2022 - 7:00am

Northern Trust (Nasdaq: NTRS) today announced it has been appointed by Arab Fund for Economic and Social Development (AFESD) to provide a range of asset servicing solutions spanning global custody, financial reporting, securities finance, private equity administration, performance measurement and compliance monitoring.

Key Points: 
  • Northern Trust (Nasdaq: NTRS) today announced it has been appointed by Arab Fund for Economic and Social Development (AFESD) to provide a range of asset servicing solutions spanning global custody, financial reporting, securities finance, private equity administration, performance measurement and compliance monitoring.
  • We are pleased to be supporting AFESD and its investment activities, said Michael Slater, head of Middle East and Africa at Northern Trust.
  • Northern Trust Corporation (Nasdaq: NTRS) is a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, affluent families and individuals.
  • Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S.

Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007

Retrieved on: 
Wednesday, July 6, 2022 - 5:40am

Dosing the first participant is an important milestone for the IMG-007 program, said Dr Jonathan Wang, Chairman and Chief Executive Officer of Inmagene.

Key Points: 
  • Dosing the first participant is an important milestone for the IMG-007 program, said Dr Jonathan Wang, Chairman and Chief Executive Officer of Inmagene.
  • We hope the data will help us demonstrate that IMG-007 is one of the strongest OX40 antagonist drug candidates worldwide.
  • It was originally discovered by HUTCHMED, with Inmagene assuming development responsibility at the candidate stage.
  • Inmagene has formed strategic partnerships with multiple partners, such as HUTCHMED and Affibody AB, to develop highly innovative drug candidates.

FTI Consulting Strengthens Corporate Finance & Restructuring Segment with Appointment of Senior Managing Director Martin Wong

Retrieved on: 
Wednesday, July 6, 2022 - 12:00am

SINGAPORE, July 05, 2022 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced its continued investment in its Corporate Finance & Restructuring segment in Asia with the appointment of Martin Wong as a Senior Managing Director.

Key Points: 
  • SINGAPORE, July 05, 2022 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced its continued investment in its Corporate Finance & Restructuring segment in Asia with the appointment of Martin Wong as a Senior Managing Director.
  • Based in Singapore, Mr. Wong brings over 24 years of experience in rehabilitative corporate restructuring and insolvency administration involving judicial management appointments, schemes of arrangement, receiverships, and voluntary and court liquidation.
  • Mr. Wong also engages in business advisory services, helping underperforming corporations improve financial performance.
  • I am delighted to welcome Martin to our growing Corporate Finance & Restructuring segment in Asia, said Vincent Fok , Head of Asia Corporate Finance & Restructuring at FTI Consulting.

Upwork to Report Second Quarter 2022 Financial Results on July 27, 2022

Retrieved on: 
Tuesday, July 5, 2022 - 9:05pm

SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the worlds largest work marketplace that connects businesses with independent talent, as measured by gross services volume (GSV), today announced that it will report its financial results for the second quarter of 2022 on Wednesday, July 27, 2022 after market close.

Key Points: 
  • SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the worlds largest work marketplace that connects businesses with independent talent, as measured by gross services volume (GSV), today announced that it will report its financial results for the second quarter of 2022 on Wednesday, July 27, 2022 after market close.
  • The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.
  • An audio replay of the conference call will be available for one week following the call and will be archived via webcast on the Upwork Investor Relations website at investors.upwork.com for approximately one year.
  • Upwork is the worlds largest work marketplace that connects businesses with independent talent, as measured by GSV.

Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors

Retrieved on: 
Tuesday, July 5, 2022 - 10:00pm

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.
  • We are pleased to welcome Dr. Shan to Cerus Board of Directors, said Daniel Swisher, Chair of the Board.
  • I am delighted to be joining the Board of Directors at Cerus during this exciting time in the Companys history, said Dr. Shan.
  • Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company.

PenFed Credit Union Supports Veterans and First Responders with Disabilities with $50,000 Donation to America's VetDogs at Washington Nationals Game

Retrieved on: 
Tuesday, July 5, 2022 - 9:40pm

TYSONS, Va., July 5, 2022 /PRNewswire/ -- PenFed Credit Union, the nation's second-largest federal credit union, furthered its commitment to the military community with a $50,000 donation to America's VetDogs to help veterans and first responders with disabilities. PenFed Credit Union President/CEO James Schenck presented the check to America's VetDogs President/CEO John Miller during pre-game activities on the field of Nationals Park before the team squared off against the Miami Marlins during its Patriotic Series: Independence Day Game presented by PenFed.

Key Points: 
  • TYSONS, Va., July 5, 2022 /PRNewswire/ -- PenFed Credit Union , the nation's second-largest federal credit union, furthered its commitment to the military community with a $50,000 donation to America's VetDogs to help veterans and first responders with disabilities.
  • "PenFed has seen firsthand the positive impact service dogs have on the lives of veterans and first responders with disabilities," said Schenck.
  • "America's VetDogs is so grateful to have such a dedicated partner in PenFed Credit Union," said America's VetDogs president and CEO John Miller.
  • To learn more about PenFed Credit Union, visit PenFed.org, like us on Facebook and follow us @PenFed on Twitter.

Weatherford Announces Second-Quarter 2022 Conference Call

Retrieved on: 
Tuesday, July 5, 2022 - 9:30pm

HOUSTON, July 5, 2022 /PRNewswire/ -- Weatherford International plc (NASDAQ: WFRD) ("Weatherford" or the "Company") will host a conference call on Thursday, July 28, 2022 to discuss the Company's results for the second quarter ended June 30, 2022.

Key Points: 
  • HOUSTON, July 5, 2022 /PRNewswire/ -- Weatherford International plc (NASDAQ: WFRD) ("Weatherford" or the "Company") will host a conference call on Thursday, July 28, 2022 to discuss the Company's results for the second quarter ended June 30, 2022.
  • Prior to the conference call, the Company will issue a press release announcing the results and the associated presentation slides will be uploaded to the investor relations section of the Weatherford website.
  • Alternatively, the conference call can be accessed by registering in advance (which will provide a PIN for immediate access) or by dialing +1 877-328-5344 (within the U.S.) or +1 412-902-6762 (outside of the U.S.) and asking for the Weatherford conference call.
  • A telephonic replay of the conference call will be available until August 10, 2022, at 5:00 p.m. Eastern Time.